Hiniker Susan M, Knox Susan J
Department of Radiation Oncology, Stanford University, Stanford, CA.
Department of Radiation Oncology, Stanford University, Stanford, CA.
Semin Oncol. 2014 Dec;41(6):702-13. doi: 10.1053/j.seminoncol.2014.09.019. Epub 2014 Oct 6.
Radiation therapy and immunotherapy are both well-established treatments for malignant disease. Radiotherapy has long been utilized for purposes of providing local tumor control, and the recent success with novel immunomodulatory agents has brought immunotherapy into the forefront of clinical practice for the treatment of many tumor types. Although radiotherapy has traditionally been thought to mediate tumor regression through direct cytotoxic effects, it is now known that radiation also alters the local tumor microenvironment with effects on both the local and systemic anti-tumor immune response. There is growing evidence that the rational integration of the immunomodulatory effects of radiotherapy with the expanding armamentarium of clinically approved immunotherapeutics can yield potent anti-tumor responses exceeding the benefit of either therapy alone. Here we summarize current approaches to the combination of immunotherapy with radiation therapy.
放射治疗和免疫治疗都是治疗恶性疾病的成熟方法。放射治疗长期以来一直用于实现局部肿瘤控制,而新型免疫调节药物最近取得的成功已使免疫治疗成为治疗多种肿瘤类型的临床实践前沿。尽管传统上认为放射治疗是通过直接细胞毒性作用介导肿瘤消退,但现在已知辐射还会改变局部肿瘤微环境,对局部和全身抗肿瘤免疫反应产生影响。越来越多的证据表明,将放射治疗的免疫调节作用与临床批准的免疫治疗药物不断扩大的药库进行合理整合,可以产生强大的抗肿瘤反应,超过单独使用任何一种治疗的益处。在此,我们总结了免疫治疗与放射治疗联合的当前方法。